Smith & Nephew DYONICS™ PLAN brings first-of-its-kind, individualized surgical planning to hip arthroscopy

Smith & Nephew DYONICS™ PLAN brings first-of-its-kind, individualized surgical
                         planning to hip arthroscopy

PR Newswire

LONDON, March 12, 2014

LONDON, March 12, 2014 /PRNewswire/ -- Smith & Nephew (NYSE:SNN;LSE:SN), the
global medical technology business, will launch its DYONICS PLAN Hip
Impingement Planning System at this week's American Academy of Orthopaedic
Surgeons (AAOS) annual meeting in New Orleans. Unlike standard imaging tools,
DYONICS PLAN is a revolutionary 3D software system that allows surgeons to
visualize, assess and generate a comprehensive surgical report for each
patient's unique Femoroacetabular impingement (FAI) surgery before that
patient ever enters the operating room.

Smith & Nephew logo

"Performing impingement surgery in the hip without the report is like putting
in a total knee without cutting guides," says Dr. Bryan Kelly of New York, NY.
"DYONICS PLAN takes the guesswork out of every case."

DYONICS PLAN provides a standardized and repeatable way of assessing hip
impingement treatment options based on data from low-dose[i] CT scans. The
software, which is easily installed on a surgeon's computer, also allows for
interactive adjustments based on a surgeon's clinical experience.

Using the DYONICS PLAN 3D model of the patient's joint, a surgeon can perform
variety of dynamic range-of-motion (ROM) simulations to identify the degree
and location of hip impingement. The ROM feature can also be used to
individualize a surgical plan based on a patient's lifestyle or
sports-specific motion, or to assess impact of different surgical strategies
on patient outcomes. Once finalized, the system generates a comprehensive
surgical plan than can be exported into either HTML or PDF format.

"DYONICS PLAN offers surgeons the ability to understand and address a
patient's hip impingement on a level that goes beyond anything possible with
standard imaging tools," explains Brad Cannon, President, Endoscopy, Trauma
and Extremities for Smith & Nephew. "Because it tells a more complete story
about each patient's impingement and how best to surgically treat it, it also
provides an exceptionally visual tool for patient communication."

DYONICS PLAN was designed in conjunction with four of the leading surgeons in
hip arthroscopy: Dr. Asheesh Bedi of Ann Arbor, MI; Dr. J.W. Thomas Byrd of
Nashville, TN; Dr. Bryan Kelly and Dr. Christopher Larson of Edina, MN.

Surgeons can see a demonstration of DYONICS PLAN at the Smith & Nephew booth
at this year's AAOS meeting (#5229 in Hall G) or by visiting

Editor's Note:

FAI is a condition where the bones of the hip are abnormally shaped. Because
they do not fit together perfectly, the hip bones rub against each other and
cause damage to the joint, including cartilage damage and bone spurs.[ii]

About Smith & Nephew

Smith & Nephew is a global medical technology business dedicated to helping
healthcare professionals improve people's lives. With leadership positions in
Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and
Trauma & Extremities, Smith & Nephew has around 11,000 employees and a
presence in more than 90 countries. Annual sales in 2013 were more than $4.3
billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).

For more information about Smith & Nephew, please visit our corporate website, follow @SmithNephewplc on Twitter or visit
SmithNephewplc on

Forward-looking Statements
This document may contain forward-looking statements that may or may not prove
accurate. For example, statements regarding expected revenue growth and
trading margins, market trends and our product pipeline are forward-looking
statements. Phrases such as "aim", "plan", "intend", "anticipate",
"well-placed", "believe", "estimate", "expect", "target", "consider" and
similar expressions are generally intended to identify forward-looking
statements. Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual results to
differ materially from what is expressed or implied by the statements. For
Smith & Nephew, these factors include: economic and financial conditions in
the markets we serve, especially those affecting health care providers, payers
and customers; price levels for established and innovative medical devices;
developments in medical technology; regulatory approvals, reimbursement
decisions or other government actions; product defects or recalls; litigation
relating to patent or other claims; legal compliance risks and related
investigative, remedial or enforcement actions; strategic actions, including
acquisitions and dispositions, our success in performing due diligence,
valuing and integrating acquired businesses; disruption that may result from
transactions or other changes we make in our business plans or organisation to
adapt to market developments; and numerous other matters that affect us or our
markets, including those of a political, economic, business, competitive or
reputational nature. Please refer to the documents that Smith & Nephew has
filed with the U.S. Securities and Exchange Commission under the U.S.
Securities Exchange Act of 1934, as amended, including Smith & Nephew's most
recent annual report on Form 20-F, for a discussion of certain of these
factors. Any forward-looking statement is based on information available to
Smith & Nephew as of the date of the statement. All written or oral
forward-looking statements attributable to Smith & Nephew are qualified by
this caution. Smith & Nephew does not undertake any obligation to update or
revise any forward-looking statement to reflect any change in circumstances or
in Smith & Nephew's expectations.

^™ ^ Trademark of Smith & Nephew. Certain marks registered US Patent and
Trademark Office.

[i] Low-dose scan protocol reduces radiation by approximately 50-percent
compared to standard CT protocol. CT Protocol Report, HIPS. Document number
15001984, 2013. Data on file at Smith & Nephew

[ii] American Academy of Orthopaedic Surgeons website

Logo -

SOURCE Smith & Nephew

Contact: Media, Joe Metzger, Smith & Nephew,+1 (978) 749-1330 ;
Investor/Analyst, Phil Cowdy, Smith & Nephew, +44 (0)20 7401 7646
Press spacebar to pause and continue. Press esc to stop.